Progress with a Recombinant Whooping Cough Vaccine: A Review

Bordet J Gengou O . Le microbe de la coqueluche. Ann Inst Pasteur 1906; 20: 731–41

Felton HM Willard CY . Current status of prophylaxis by Hemophilus pertussis vaccine. JAMA 1944; 126: 294–9

Cherry JD . The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: A comparative study. Curr Probl Pediatr 1984; 14: 1–78

Madsen T . Vaccination against whooping cough. JAMA 1933; 101: 187–8

Kendrick PL Eldering G . A study in active immunization against pertussis. Am J Hyg 1939; 29: 133–53

Bass JW Stephenson SR . The return of pertussis. Pediatr Infect Dis 1987; 6: 141–4

Cherry JD Brunell PA Golden GS Karzon DT . Report of the task force on pertussis and pertussis immunization — 1988. Pediatrics 1988; 81 (Suppl): 939–84

Romanus V Jonsell R Bergquist S-O . Pertussis in Sweden after cessation of general immunization in 1979. Pediatr Infect Dis 1987; 6: 364–71

Kimura M Kuno-Sakai H . Acellular pertussis vaccines and fatal infections. Lancet 1988; 1: 881–2

Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden — Protective efficacy and adverse events. Lancet 1988; i: 955–60

Olin P Storsaeter J Romanus V . The efficacy of acellular pertussis vaccine. JAMA 1989; 261: 560

Pittman M . The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis 1984; 3: 467–86

Pittman M . Neurotoxicity of Bordetella pertussis. Neurotoxicology 1986; 7: 53–68

Weiss AA Hewlett EL . Virulence factors of Bordetella pertussis. Ann Rev Microbiol 1986; 40: 661–86

Burnette WN . The advent of recombinant pertussis vaccines. Bio/Technology 1990; 8: 1002–5

Locht C Barstad PA Coligan JE , et al. Molecular cloning of pertussis toxin genes. Nucl Acids Res 1986; 14: 3251–61

Locht C Keith JM . Pertussis toxin gene: Nucleotide sequence and genetic organization. Science 1986; 232: 1258–64

Tamura M Nogimori K Murai S , et al. Subunit structure of the islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 1982; 21: 5516–22

Katada T Tamura M Ui M . The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch Biochem Biophys 1983; 224: 290–8

Tamura M Nogimori K Yajima M Ase K Ui M . A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem 1983; 258: 6756–61

Sato H Ito A Chiba J Sato Y . Monoclonal antibody against pertussis toxin: Effect on toxin activity and pertussis infections. Infect Immun 1984; 46: 422–8

Burnette WN Mar VL Cieplak W , et al. Direct expression of Bordetella pertussis toxin subunits to high levels in Escherichia coli. Bio/Technology 1988; 6: 699–706

Cieplak W Burnette WN Mar VL , et al. Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant. Proc Natl Acad Sci USA 1988; 85: 4667–71

Burnette WN Cieplak W Mar VL Kaljot KT Sato H Keith JM . Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science 1988; 242: 72–4

Kaslow HR Schlotterbeck JD Mar VL Burnette WN . Alkylation of cysteine 41, but not cysteine 200, decreases the ADP-ribosyltransferase activity of the S1 subunit of pertussis toxin. J Biol Chem 1989; 264: 6386–90

Cieplak W jr Mar VL Burnette WN Keith JM Locht C . Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD⁺. Biochem J 1990; 268: 547–51

Lobet Y Cieplak W jr Smith SG Keith JM . Effects of mutations on the enzyme activity and immuno-reactivity of the S1 subunit of pertussis toxin. Infect Immun 1989; 57: 3660–2

Bartley TD Whiteley DW Mar VL Burns DL Burnette WN . Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proc Natl Acad Sci USA 1989; 86: 8353–7

Hewlett EL Sauer KT Myers GA Cowell JL Guerrant RL . Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun 1983; 40: 1198–203

Burns DL Kenimer JG Manclark CR . Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun 1987; 55: 24–8

Arciniega JL Shahin RD Burnette WN , et al. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin. Infect Immun 1991; 59: 3407–10

Pizza M Covacci A Bartoloni A , et al. Mutants of pertussis toxin suitable for vaccine development Science 1989; 246: 497–500

Podda A Nencioni L De Magistris MT , et al. Metabolic, humoral, and cellular responses in adult volunteers immunized with genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med 1990; 172: 861–8